Veterinary Medicines

EFFIPRO 268 MG SPOT-ON SOLUTION FOR LARGE DOGS

Authorised
  • Fipronil
Download as PDF

Product identification

Medicine name:
EFFIPRO 268 MG SPOT-ON SOLUTION FOR LARGE DOGS
EFFIPRO 268 mg spot-on oplossing voor grote honden
Active substance:
  • Fipronil
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Fipronil
    268.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX15
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Box containing 2 pipettes of 2.68 mL
  • Box containing 3 pipettes of 2.68 mL
  • Box containing 4 pipettes of 2.68 mL
  • Box containing 6 pipettes of 2.68 mL
  • Box containing 8 pipettes of 2.68 mL
  • Box containing 12 pipettes of 2.68 mL
  • Box containing 24 pipettes of 2.68 mL
  • Box containing 30 pipettes of 2.68 mL
  • Box containing 60 pipettes of 2.68 mL
  • Box containing 90 pipettes of 2.68 mL
  • Box containing 150 pipettes of 2.68 mL
  • Box containing 1 blister pack of 1 pipette of 2.68 mL
  • Box containing 2 blister packs of 1 pipette of 2.68 mL
  • Box containing 3 blister packs of 1 pipette of 2.68 mL
  • Box containing 4 blister packs of 1 pipette of 2.68 mL
  • Box containing 6 blister packs of 1 pipette of 2.68 mL
  • Box containing 8 blister packs of 1 pipette of 2.68 mL
  • Box containing 12 blister packs of 1 pipette of 2.68 mL
  • Box containing 24 blister packs of 1 pipette of 2.68 mL
  • Box containing 30 blister packs of 1 pipette of 2.68 mL
  • Box containing 60 blister packs of 1 pipette of 2.68 mL
  • Box containing 90 blister packs of 1 pipette of 2.68 mL
  • Box containing 150 blister packs of 1 pipette of 2.68 mL
  • Box containing 1 pipette of 2.68 mL

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 102117
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0377/003
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 24/01/2024
Download